ロード中...
Surgical Downstaging in an Open-Label Phase II Trial of Denosumab in Patients with Giant Cell Tumor of Bone
BACKGROUND: Surgical resection with curative intent for giant cell tumor of bone (GCTB) may be associated with severe morbidity. This interim analysis evaluated reduction in surgical invasiveness after denosumab treatment in patients with resectable GCTB. METHODS: Patients with primary or recurrent...
保存先:
| 出版年: | Ann Surg Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4531146/ https://ncbi.nlm.nih.gov/pubmed/26033180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-015-4634-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|